Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies and Hepatic Impairment

Interventions

DRUG: pelabresib

Sponsor

Novartis Pharmaceuticals